<DOC>
	<DOC>NCT01262677</DOC>
	<brief_summary>Approximately 30% percent of subjects with partial seizures are refractory to treatment with single or combination antiepileptic drugs. The present study will compare the efficacy of two different dosages of pregabalin CR dosed once daily as compared to placebo, when used as adjunctive therapy in subjects requiring adjunctive therapy for partial onset epilepsy, using a randomized, parallel group design.</brief_summary>
	<brief_title>Once-A-Day Pregabalin For Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis of epilepsy with partial onset seizures (seizures may be simple or complex, with or without evolution into a bilateral, convulsive seizure) Currently taking 1 to 3 anitepilepsy medicines (AEDs) at stable dosages, and who have taken at least 2 prior (or ongoing) AEDs Primary generalized seizures (for example, absence, myoclonic seizures or LennoxGastaut Syndrome) Status epilepticus within one year prior to screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Partial epilepsy</keyword>
	<keyword>partial seizures</keyword>
	<keyword>epilepsy</keyword>
	<keyword>seizures</keyword>
	<keyword>adjunctive therapy</keyword>
	<keyword>intervention</keyword>
	<keyword>controlled-release</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>seizure</keyword>
</DOC>